Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides comprehensive medical services with multiple clinics across southwestern Georgia regions. Founded in 2011; operates clinics in Lanchkhuti, Ozurgeti, Chokhatauri, and Kaspi regions.
Subsidiary of Aversi-Pharma (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 1,678 | 3,515 | 1,956 | 3,393 | 5,241 | 7,569 | 6,743 | 998 | -7.2% |
| Net Cash used in Investing Activities | 0 | 4,243 | 2,855 | 1,662 | 2,057 | 4,353 | 4,676 | 2,804 | -6.7% |
| Free Cash Flow (OCF − Capex proxy) | 1,678 | 728 | 899 | 1,731 | 3,184 | 3,216 | 2,067 | 1,806 | nmf |
| Net Cash from Financing Activities | 0 | 660 | 565 | 172 | 3,539 | 2,236 | 4,311 | 1,770 | +17.9% |
| Net Change in Cash (before FX) | 1,678 | 68 | 334 | 1,559 | 355 | 980 | 2,244 | 37 | nmf |
| Net Change in Cash (incl. FX) | 1,678 | 68 | 334 | 1,559 | 355 | 980 | 2,244 | 37 | nmf |
| Cash at Beginning of Year | 0 | 524 | 456 | 122 | 1,682 | 1,327 | 2,307 | 63 | -29.7% |
| Cash at End of Year | 0 | 456 | 122 | 1,682 | 1,327 | 2,307 | 63 | 27 | -37.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →